Estrogen Receptors

Lactandrate targets the estrogen receptor alpha (ERα) as a D-high nitrogen steroid alkylating agent. It exhibits a significant growth inhibitory effect on breast cancer cells, with a GI50 value ranging from 5 to 65 μM. In vivo studies have demonstrated its anti-tumor activity in mouse models of breast cancer, including MXT and CD8F1 strain tumors, as well as in human xenograft MX-1 models. Lactandrate serves as a valuable reagent for research in cancer biology, particularly in studying estrogen receptor modulation and breast cancer therapeutics.

Glyceollin I is a selective estrogen receptor (ER) modulator that exhibits anticancer, antioxidant, and anti-inflammatory activities. This compound is particularly promising for research in estrogen-related cancers, such as breast and ovarian cancer, as well as metabolic disorders, including hypercholesterolemia. Its unique mechanism enables the investigation of therapeutic strategies targeting estrogen pathways in various disease states.

4-tert-Octylphenol monoethoxylate is a non-steroidal estrogen that functions as an alkylphenolethoxylate (APE), specifically deriving from the breakdown of non-ionic surfactants such as 4-tert-octylphenol polyethoxylate. It exhibits estrogenic activity, making it relevant in studies of endocrine disruption and environmental toxicology. This compound has been detected in wastewater effluent, emphasizing its significance in research related to environmental contamination and its impact on aquatic ecosystems.

ERα/ERβ antagonist-1 is a selective antagonist targeting estrogen receptors ERα and ERβ. It inhibits the activity of these receptors in a dose-dependent manner, demonstrating significant effects in HepG2 liver cell lines. This compound is valuable for research applications focused on estrogen signaling and its implications in various biological processes, including hormone-related diseases and cancer studies.

4-(Ethoxymethyl)phenol is an effective antioxidant that targets oxidative stress mechanisms. Derived from the leaf extract of Amburana cearensis, it exhibits in vitro cytogenotoxic properties, making it a valuable compound for investigations into respiratory diseases and inflammation. This reagent can be utilized in research focused on oxidative damage and its implications in various biological processes.

Neo-sagittasine A is an estrogen synthesis promoting factor that enhances estrogen biosynthesis in human ovarian granulosa-like KGN cells. This compound is isolated from the plant Epimedium brevifolium and is useful in research applications related to reproductive biology and hormone regulation. Its ability to promote estrogen production makes it a valuable reagent for studies investigating endocrine functions and associated disorders.

10-Chloroestra-1,4-diene-3,17-dione is an analog of the estrogen receptor, primarily targeting this pathway to modulate estrogenic activity. This compound demonstrates significant biological activity in studies involving hormone-related signaling and receptor interactions. It is commonly utilized in research applications focused on endocrine modulation, cancer biology, and the exploration of estrogen-related mechanisms in cellular processes.

(-)-Erteberel is a selective agonist of the estrogen receptor beta (ERβ). This compound plays a significant role in the investigation of diseases influenced by ERβ, including prostate cancer. Its specificity for ERβ makes it a valuable tool for exploring the receptor's biological functions and potential therapeutic applications.

4-Hydroxytoremifene is an estrogen receptor antagonist that effectively inhibits the binding of estradiol to its receptor in target tissues. This compound is utilized in research to explore mechanisms of estrogen action and its role in various hormonal therapies, particularly in the context of breast cancer. Its ability to modulate estrogen signaling makes it a valuable tool for studying hormone-responsive diseases.

LY88074 Trimethyl Ether is an anti-estrogen deficiency agent that targets estrogen signaling pathways. It effectively inhibits conditions associated with estrogen deprivation syndrome, such as osteoporosis and hyperlipidemia. This compound serves as a valuable tool in research applications focused on understanding and mitigating the effects of estrogen deficiency.

NNC45-0781 is an estrogen receptor (ER) partial agonist with tissue-selective properties. It exhibits key biological activity by modulating ER signaling pathways, making it valuable for research on estrogen-related physiological processes and conditions. NNC45-0781 is particularly relevant in investigations of hormone-dependent cancers and the study of estrogen's role in reproductive biology.

Estriol is an orally active estrogen that acts as an agonist of estrogen receptors ERα and ERβ. It exhibits antagonistic activity against GPR30 in estrogen receptor-negative breast cancer cells, making it a valuable compound in cancer research. Additionally, Estriol has been shown to mitigate disease severity via immunomodulatory mechanisms that reduce tissue inflammation, while also demonstrating proconvulsant properties. Its diverse biological activities make it relevant for studies on hormone-related disorders and cancer therapeutics.

Estradiol valerate is a synthetic form of the estrogen hormone with a primary mechanism as an agonist of the estrogen receptor (ER). This compound is utilized in various research applications, including hormone replacement therapy studies and investigations into estrogen-mediated biological processes. Its ability to modulate estrogen receptor activity makes it a valuable reagent for exploring the roles of estrogen in development, reproduction, and endocrine function.

Tracheloside is an antiestrogenic lignin known for promoting keratinocyte proliferation through the stimulation of the ERK1/2 signaling pathway. This compound exhibits significant potential in enhancing wound healing and tissue regeneration processes. Its ability to modulate cellular responses makes Tracheloside a valuable tool for research in dermatological and regenerative medicine applications.

Triphenylethylene is an antiestrogen agent that primarily functions by inhibiting L-type Ca2+ channels. This compound displays weak estrogenic activity and has been shown to relax duodenal intestinal muscle. Triphenylethylene is useful in research applications focusing on estrogen receptor modulation and the investigation of calcium channel dynamics in smooth muscle tissues.

Bisphenol C is a selective estrogen receptor-α (ERα) agonist and estrogen receptor-β (ERβ) antagonist, exhibiting IC50 values of 2.65 nM and 1.94 nM for ERα and ERβ, respectively. This compound is significant in research related to endocrine disruption and estrogenic activity. Its applications extend to investigating the biological effects associated with environmental exposure to endocrine disruptors found in common consumer products such as plastics and food packaging.

Dienestrol diacetate targets the estrogen receptor, functioning as a synthetic nonsteroidal phenolic compound with established estrogenic activity. It effectively mimics the effects of estrogen in vivo, influencing the reproductive system and associated biological processes. This compound is under investigation for its potential to inhibit hormone-related diseases, including those arising from estrogen deficiency, and may have applications in hormone replacement therapy.

Ethamoxytriphetol, a nonsteroidal antiestrogen, functions by blocking estrogen receptor activity, thereby inhibiting estrogen-mediated cellular processes. This compound demonstrates significant biological activity in the modulation of hormone-dependent tumors, making it valuable in cancer research, particularly in breast cancer studies. Its application extends to investigating the mechanisms of antiestrogen resistance and exploring novel therapeutic strategies.

Diethylstilbestrol diphosphate is a potent estrogen receptor agonist and a prodrug of diethylstilbestrol. It exhibits significant anti-gonadotropin activity, making it a valuable tool in the research of prostate cancer. This compound aids in elucidating mechanisms of estrogen signaling and its implications in various hormonal responses, contributing to investigations in endocrine-related cancers.